; and (v) the average street price for the calendar year and the highest known street price during the preceding 10-year period. (B) For the calendar year and each of the previous three years data sufficient to show, disaggregated by State and, to the extent feasible, by region within a State, county, or city, the following: (i) The number of fatal and non-fatal overdoses caused by each drug identified under subparagraph (A)(i). (ii) The prevalence of substance use disorders. (iii) The number of individuals who have received substance use disorder treatment, including medication assisted treatment, for a substance use disorder, including treatment provided through publicly-financed health care programs. (iv) The extent of the unmet need for substance use disorder treatment, including the unmet need for medication-assisted treatment. (C) Data sufficient to show the extent of prescription drug diversion, trafficking, and misuse in the calendar year and each of the previous 3 calendar years. (D) Any quantifiable measures the Director determines to be appropriate to detail progress toward the achievement of the goals of the National Drug Control Strategy. (e) Access to information (1) In general Upon the request of the Director, the head of any National Drug Control Program Agency shall cooperate with and provide to the Director any statistics, studies, reports, and other information prepared or collected by the agency concerning the responsibilities of the agency under the National Drug Control Strategy that relate to— (A) drug control